Answers are grounded in this paper and cite their sources.
Maxillofacial bone defects can be treated with autologous bone grafting, but there are limitations such as the amount of excisable bone and larger surgical invasiveness. To overcome these limitations, various biomaterials are tested as possible substitutions of bone graft. Furthermore, to give osteoinductivities to artificial biomaterials, bone morphogenetic protein (BMP) useful as protein has been focused. With aging of the population, the application of biomaterials will have to be necessary for the elderly. Along this stream, we have performed studies on the osteogenic ability of BMP and the relationship between osteogenic ability of BMP and aging.
No takes yet. Share an insight, caveat, or question.
Hara et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: